This document discusses male infertility, including its definition, causes, evaluation, and treatment options. It notes that male factors contribute to 40% of infertility cases. Causes can be pre-testicular, testicular, or post-testicular and include genetic conditions, infections, varicocele, hormonal imbalances, and blockages. Evaluation involves history, exam, semen analysis, genetic/radiographic tests. The goal is to identify reversible causes, plan ART for irreversible conditions, and detect issues affecting offspring health. Treatment depends on the underlying cause and may involve surgery, medication, or ART like IVF/ICSI.
This document provides an overview of male infertility, including its definition, causes, evaluation, and treatment options. It discusses factors that can cause infertility, such as varicocele, genetic disorders, hormonal imbalances, and problems with sperm production or transport. The evaluation of male infertility involves assessing medical history, performing a physical exam, analyzing semen samples, and testing for hormonal and genetic abnormalities if indicated. Treatment depends on the underlying cause but may include surgery, hormone therapy, assisted reproduction techniques like IVF, or empiric supplements for some issues.
This document provides an overview of the evaluation of male infertility. It defines infertility and its prevalence. The main causes of male infertility are varicocele (35-40%), idiopathic factors (25%), and infection (10%). Evaluation of male infertility includes obtaining a history, physical exam, semen analysis, and hormonal evaluation. The history focuses on sexual, medical, surgical, and family histories. The physical exam evaluates the genitals and secondary sex characteristics. The basic lab evaluation includes at least two semen analyses. Together this evaluation aims to identify correctable and non-correctable causes of infertility.
Male infertility is the inability to conceive after 1 year of unprotected intercourse, affecting 15% of couples. It can be caused by issues with sperm production (testicular) or blockages preventing ejaculation (post-testicular). Diagnosis involves medical history, physical exam, semen analysis, and additional tests. Treatment options include surgery, medication, assisted reproduction like IUI or IVF/ICSI. The goal is to identify the underlying cause and manage it to improve chances of conception.
This document discusses the evaluation of male infertility, which is often neglected. It outlines the components of a complete evaluation, including history, physical exam, semen analysis, imaging, and hormonal and genetic testing. Lifestyle factors like smoking, alcohol, obesity, medications, and environmental exposures can negatively impact fertility. A physical exam evaluates secondary sex characteristics, genitals, and tests for issues like varicocele. Semen analysis assesses volume, concentration, motility, and morphology. Additional tests may include ultrasounds, hormone levels, sperm DNA fragmentation, and genetic testing. Finding the cause of infertility helps determine the best treatment approach.
This document discusses various surgical sperm retrieval techniques for assisted reproduction, including:
1) Percutaneous epididymal sperm aspiration (PESA) and microsurgical epididymal sperm aspiration (MESA) are used to retrieve sperm from the epididymis in cases of obstructive azoospermia.
2) Testicular sperm aspiration (TESA) and testicular sperm extraction (TESE) are used to retrieve sperm directly from the testes in cases of non-obstructive azoospermia or previous failed epididymal sperm retrieval.
3) Microsurgical testicular sperm extraction (Micro-TESE) uses an operating microscope to identify and extract semin
Practical guide lines for evaluation of male infertilty.Sadashiv Bhole
This document provides an overview of male infertility, including definitions, prevalence, causes, evaluation, and treatment. It discusses pre-testicular, testicular, and post-testicular causes of infertility and lists various medical history, physical exam, and diagnostic tests. Key points include that semen analysis and treatment of clinical varicoceles prior to ICSI may improve outcomes for some men. The take-home message emphasizes assessing and correcting any surgical or endocrinological abnormalities to optimize fertility treatment results.
Dr. Sujoy Dasgupta is a reproductive medicine specialist who has extensive training and experience in India and abroad. He lists his qualifications and areas of practice. The document then discusses limitations of the 2010 WHO semen analysis guidelines, significance of sperm DNA fragmentation testing, definitions of mild and severe male factor infertility, and investigations and treatment approaches for various causes of male infertility including varicocele, congenital bilateral absence of vas deferens, cryptorchidism, hormonal abnormalities, and azoospermia. Key advice includes thorough evaluation and evidence-based therapies over long-term use of unproven drugs, and considering sperm retrieval and assisted reproduction rather than assuming donor sperm is the only option.
This document provides an overview of male infertility, including its definition, causes, evaluation, and treatment options. It discusses factors that can cause infertility, such as varicocele, genetic disorders, hormonal imbalances, and problems with sperm production or transport. The evaluation of male infertility involves assessing medical history, performing a physical exam, analyzing semen samples, and testing for hormonal and genetic abnormalities if indicated. Treatment depends on the underlying cause but may include surgery, hormone therapy, assisted reproduction techniques like IVF, or empiric supplements for some issues.
This document provides an overview of the evaluation of male infertility. It defines infertility and its prevalence. The main causes of male infertility are varicocele (35-40%), idiopathic factors (25%), and infection (10%). Evaluation of male infertility includes obtaining a history, physical exam, semen analysis, and hormonal evaluation. The history focuses on sexual, medical, surgical, and family histories. The physical exam evaluates the genitals and secondary sex characteristics. The basic lab evaluation includes at least two semen analyses. Together this evaluation aims to identify correctable and non-correctable causes of infertility.
Male infertility is the inability to conceive after 1 year of unprotected intercourse, affecting 15% of couples. It can be caused by issues with sperm production (testicular) or blockages preventing ejaculation (post-testicular). Diagnosis involves medical history, physical exam, semen analysis, and additional tests. Treatment options include surgery, medication, assisted reproduction like IUI or IVF/ICSI. The goal is to identify the underlying cause and manage it to improve chances of conception.
This document discusses the evaluation of male infertility, which is often neglected. It outlines the components of a complete evaluation, including history, physical exam, semen analysis, imaging, and hormonal and genetic testing. Lifestyle factors like smoking, alcohol, obesity, medications, and environmental exposures can negatively impact fertility. A physical exam evaluates secondary sex characteristics, genitals, and tests for issues like varicocele. Semen analysis assesses volume, concentration, motility, and morphology. Additional tests may include ultrasounds, hormone levels, sperm DNA fragmentation, and genetic testing. Finding the cause of infertility helps determine the best treatment approach.
This document discusses various surgical sperm retrieval techniques for assisted reproduction, including:
1) Percutaneous epididymal sperm aspiration (PESA) and microsurgical epididymal sperm aspiration (MESA) are used to retrieve sperm from the epididymis in cases of obstructive azoospermia.
2) Testicular sperm aspiration (TESA) and testicular sperm extraction (TESE) are used to retrieve sperm directly from the testes in cases of non-obstructive azoospermia or previous failed epididymal sperm retrieval.
3) Microsurgical testicular sperm extraction (Micro-TESE) uses an operating microscope to identify and extract semin
Practical guide lines for evaluation of male infertilty.Sadashiv Bhole
This document provides an overview of male infertility, including definitions, prevalence, causes, evaluation, and treatment. It discusses pre-testicular, testicular, and post-testicular causes of infertility and lists various medical history, physical exam, and diagnostic tests. Key points include that semen analysis and treatment of clinical varicoceles prior to ICSI may improve outcomes for some men. The take-home message emphasizes assessing and correcting any surgical or endocrinological abnormalities to optimize fertility treatment results.
Dr. Sujoy Dasgupta is a reproductive medicine specialist who has extensive training and experience in India and abroad. He lists his qualifications and areas of practice. The document then discusses limitations of the 2010 WHO semen analysis guidelines, significance of sperm DNA fragmentation testing, definitions of mild and severe male factor infertility, and investigations and treatment approaches for various causes of male infertility including varicocele, congenital bilateral absence of vas deferens, cryptorchidism, hormonal abnormalities, and azoospermia. Key advice includes thorough evaluation and evidence-based therapies over long-term use of unproven drugs, and considering sperm retrieval and assisted reproduction rather than assuming donor sperm is the only option.
This document discusses the causes, evaluation, and treatment of male infertility. It begins by outlining the main causes of male infertility including pretesticular, testicular, post-testicular defects, and idiopathic factors. Evaluation involves a medical history, physical exam, and investigations including standard semen analysis, specialized tests, endocrine testing, and genetic tests. Treatment options are discussed including empiric treatments, therapies for specific diagnoses like varicocele or infections, assisted reproductive techniques like IUI or ICSI, and discussing when such options are appropriate based on resource availability and severity of male factor infertility. The document provides a comprehensive overview of male infertility.
This document provides an overview of the clinical management of nonobstructive azoospermia (NOA). It begins by defining NOA and explaining its challenges. It then discusses the diagnostic evaluation and differentiates between obstructive and nonobstructive causes. For NOA due to spermatogenic failure, the document outlines that the condition is irreversible and reviews sperm retrieval techniques and their success rates depending on the underlying etiology. It also notes that while biomarkers can reflect testicular function, they cannot definitively predict whether sperm will be found for retrieval.
This document provides an overview of azoospermia, which is the complete absence of sperm in semen. It classifies azoospermia as either non-obstructive or obstructive, discusses various causes such as Klinefelter's syndrome and Kallmann syndrome, and outlines examination and treatment approaches including surgical sperm retrieval techniques and IVF with ICSI. Key causes, classifications, diagnostic tests, and management strategies for azoospermia are presented.
Male infertility can be caused by various congenital or acquired factors that impair male fertility. These include urogenital abnormalities, infections, increased scrotal temperature from conditions like varicocele, endocrine disturbances, genetic abnormalities, and sometimes no identifiable cause is found. A comprehensive evaluation of male infertility includes semen analysis, physical exam, hormonal tests, ultrasound, and additional tests as needed depending on the results. Common conditions causing male infertility include genetic disorders, obstructive issues, varicocele, hypogonadism, and undescended testes. Treatment depends on the underlying cause but may include surgery, hormone therapy, or sperm retrieval techniques.
This document summarizes medical management strategies for male infertility. It discusses empirical and hormonal treatments for different types of male infertility, including hypogonadism. Specific treatments are recommended based on hormone levels and categories of infertility. For example, men with hypo-hypo infertility may benefit from recombinant hCG treatment. Aromatase inhibitors are discussed as a treatment for obesity-related infertility to reduce elevated estradiol levels. The document also covers potential benefits of medical therapy prior to sperm retrieval procedures for patients with non-obstructive azoospermia.
This document provides an overview of the evaluation and investigations for male infertility. It discusses the key components of the medical history and physical exam, including reproductive, sexual, childhood, medical, and family histories. Initial laboratory assessments include semen analysis according to WHO standards and endocrine evaluation if indicated. Imaging tools like ultrasound, Doppler ultrasound, and MRI can identify conditions affecting fertility. Traditional and modern methods are described to further evaluate couples where initial testing is normal but functional defects may still impair fertilization. A postcoital or Sims test examines sperm-mucus interaction ability.
This document discusses azoospermia, which is defined as the absence of sperm in a man's ejaculate. It covers the causes, classification, evaluation, and management of azoospermia. The main points are:
1) Azoospermia can be obstructive, caused by blockages, or non-obstructive, caused by testicular failure to produce sperm. Evaluation involves semen analysis, hormone testing, ultrasound, and sometimes genetic testing.
2) Management depends on the cause. For obstructive cases, surgery may correct blockages, while for non-obstructive cases, procedures like TESA may retrieve sperm for use in IVF/ICSI. Pretest
This document provides an overview of the diagnosis and management of male infertility. It discusses evaluating the patient's history including reproductive, medical, surgical, medication/toxin exposure and family histories. Physical exam and lab tests including semen analysis and hormones are also important. Common causes of male infertility discussed include varicocele, cryptorchidism, infections, cancers, medications/toxins and genetic factors. Lifestyle factors that can impact fertility are also addressed.
This document discusses the evaluation of male infertility. It outlines the various causes of male infertility including pretesticular, testicular, and post-testicular defects. The evaluation involves obtaining a history, physical exam, standard semen analysis, specialized tests such as endocrine testing and genetic tests, and specialized semen analyses to determine the underlying cause. The standard semen analysis evaluates semen volume, pH, sperm concentration, motility, morphology, round cells, and leukocytes. Abnormal findings can help localize the cause of infertility to the testes, epididymis, or other structures.
Micro-TESE as the latest option for the worst azoospermia scenariosSandro Esteves
This document summarizes information from a presentation on azoospermia and microsurgical testicular sperm extraction (Micro-TESE). It defines obstructive and non-obstructive azoospermia and compares conventional sperm retrieval techniques to Micro-TESE. Micro-TESE has higher sperm retrieval rates compared to conventional TESE, especially for men with non-obstructive azoospermia. It allows identification and preservation of the few seminiferous tubules that may contain sperm, minimizing damage to the testis.
This document summarizes male fertility and factors that impact sperm production and delivery. It discusses the roles of the hypothalamus, pituitary gland, testes and accessory sex organs in spermatogenesis and fertilization. It also outlines factors that can negatively influence sperm quality or quantity, such as varicoceles, infections, lifestyle, and occupational or environmental exposures. Evaluation of male fertility includes medical history, physical exam, semen analysis and additional tests as needed.
This document provides an overview of male infertility, including:
- Infertility is defined as the inability to conceive after 12 months of unprotected sex. Male factors contribute to infertility in about 50% of cases.
- Common causes of male infertility include abnormal semen parameters, infections, genetic factors, childhood illnesses, and exposure to toxins or radiation.
- Evaluation of male infertility involves medical history, physical exam including tests of the reproductive organs, semen analysis, and other tests like hormonal or genetic testing if indicated.
- Semen analysis evaluates semen volume, sperm concentration, motility, morphology, and other parameters to identify potential causes of infertility.
This document discusses male infertility and erectile dysfunction. It begins by defining infertility and discussing the prevalence of male factor infertility. The initial diagnostic workup is outlined, including medical history, physical exam, semen analysis, and imaging. Common causes of male infertility are then reviewed, including varicocele, testicular atrophy, orchitis, testicular microlithiasis, cryptorchidism, and various obstructive causes. Specific imaging findings of these conditions on ultrasound, MRI, and other modalities are presented.
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementAtef Darwish
This document discusses recommendations for assessing polycystic ovary syndrome (PCOS). It covers diagnostic criteria including irregular menstrual cycles, hyperandrogenism, polycystic ovarian morphology on ultrasound, and anti-Müllerian hormone levels. It also discusses assessing cardiovascular, metabolic, and reproductive health risks associated with PCOS, including insulin resistance, impaired glucose tolerance, diabetes, and obesity. Ethnic variations in PCOS presentation and long-term health risks are also addressed.
This document discusses ovarian reserve, which refers to a woman's reproductive potential and is a function of the number and quality of her remaining oocytes. It declines with age due to a reduction in both quantity and quality of oocytes. Several tests can assess ovarian reserve, including antral follicle count (AFC), anti-Müllerian hormone (AMH) levels, and follicle-stimulating hormone (FSH) levels. AFC and AMH are currently considered the best tests as they have less variability than FSH. These tests can help predict response to fertility treatments and live birth outcomes. While they provide useful information, age is still the strongest predictor of ovarian reserve and reproductive potential.
This document summarizes a presentation on the management of male infertility. It discusses diagnosis of male infertility including semen analysis and tests of sperm DNA integrity. It reviews medical treatments including antioxidants and treatments for specific conditions like varicocele and hypogonadism. Surgical treatments for varicocele are discussed. Assisted reproduction techniques are summarized including outcomes of ICSI for treated vs untreated varicocele and sperm retrieval techniques for obstructive and non-obstructive azoospermia. Key findings are that varicocele repair and antioxidant treatment can improve fertility outcomes, while sperm retrieved from the testes have lower DNA damage than ejaculated sperm.
Male Infertility Review 2011 By Paul J. Turek MD FACS, FRSM, Director of The ...The Turek Clinics
Lecture written and presented by Paul J. Turek MD FACS, FRSM. Dr. Turek is the Director of the The Turek Clinic in San Francisco and Former Professor and Endowed Chair at the University of California San Francisco (UCSF).
PROTOCOLSIntra Uterine Insemination (sharing personal experience) Lifecare Centre
This document provides information on intrauterine insemination (IUI), including prerequisites, indications, steps, and factors affecting success rates. It summarizes that IUI is a relatively simple and inexpensive fertility treatment that involves placing sperm directly into the uterus. Success rates are affected by factors like total motile sperm count, with counts over 5 million critical. Density gradient preparation is superior to swim-up for abnormal semen. DNA fragmentation levels also impact rates. Guidelines on when to consider IVF instead of further IUI cycles include age over 37, more than 4 failed cycles, severe male factors, and certain ovarian response patterns.
This document discusses male infertility, including its causes, classification, investigations, and normal semen values. It covers pre-testicular, testicular, and post-testicular causes of infertility. Key tests include semen analysis, hormonal assessment, immunological tests, and genetic testing. The document also provides details on the process and interpretation of semen analysis, including sperm motility, morphology, and vitality.
1) Evaluation of infertility is indicated after 12 months for women under 35 years old, 6 months for women over 35, and immediately for women over 40.
2) Certain conditions require immediate evaluation, including irregular cycles, bleeding issues, uterine/tubal abnormalities, male factor infertility, or genetic conditions.
3) A complete workup involves assessing the entire reproductive axis through history, examination, and targeted diagnostic testing to identify common causes like ovulatory disorders, endometriosis, tubal issues, and male factor infertility.
This document discusses the causes, evaluation, and treatment of male infertility. It begins by outlining the main causes of male infertility including pretesticular, testicular, post-testicular defects, and idiopathic factors. Evaluation involves a medical history, physical exam, and investigations including standard semen analysis, specialized tests, endocrine testing, and genetic tests. Treatment options are discussed including empiric treatments, therapies for specific diagnoses like varicocele or infections, assisted reproductive techniques like IUI or ICSI, and discussing when such options are appropriate based on resource availability and severity of male factor infertility. The document provides a comprehensive overview of male infertility.
This document provides an overview of the clinical management of nonobstructive azoospermia (NOA). It begins by defining NOA and explaining its challenges. It then discusses the diagnostic evaluation and differentiates between obstructive and nonobstructive causes. For NOA due to spermatogenic failure, the document outlines that the condition is irreversible and reviews sperm retrieval techniques and their success rates depending on the underlying etiology. It also notes that while biomarkers can reflect testicular function, they cannot definitively predict whether sperm will be found for retrieval.
This document provides an overview of azoospermia, which is the complete absence of sperm in semen. It classifies azoospermia as either non-obstructive or obstructive, discusses various causes such as Klinefelter's syndrome and Kallmann syndrome, and outlines examination and treatment approaches including surgical sperm retrieval techniques and IVF with ICSI. Key causes, classifications, diagnostic tests, and management strategies for azoospermia are presented.
Male infertility can be caused by various congenital or acquired factors that impair male fertility. These include urogenital abnormalities, infections, increased scrotal temperature from conditions like varicocele, endocrine disturbances, genetic abnormalities, and sometimes no identifiable cause is found. A comprehensive evaluation of male infertility includes semen analysis, physical exam, hormonal tests, ultrasound, and additional tests as needed depending on the results. Common conditions causing male infertility include genetic disorders, obstructive issues, varicocele, hypogonadism, and undescended testes. Treatment depends on the underlying cause but may include surgery, hormone therapy, or sperm retrieval techniques.
This document summarizes medical management strategies for male infertility. It discusses empirical and hormonal treatments for different types of male infertility, including hypogonadism. Specific treatments are recommended based on hormone levels and categories of infertility. For example, men with hypo-hypo infertility may benefit from recombinant hCG treatment. Aromatase inhibitors are discussed as a treatment for obesity-related infertility to reduce elevated estradiol levels. The document also covers potential benefits of medical therapy prior to sperm retrieval procedures for patients with non-obstructive azoospermia.
This document provides an overview of the evaluation and investigations for male infertility. It discusses the key components of the medical history and physical exam, including reproductive, sexual, childhood, medical, and family histories. Initial laboratory assessments include semen analysis according to WHO standards and endocrine evaluation if indicated. Imaging tools like ultrasound, Doppler ultrasound, and MRI can identify conditions affecting fertility. Traditional and modern methods are described to further evaluate couples where initial testing is normal but functional defects may still impair fertilization. A postcoital or Sims test examines sperm-mucus interaction ability.
This document discusses azoospermia, which is defined as the absence of sperm in a man's ejaculate. It covers the causes, classification, evaluation, and management of azoospermia. The main points are:
1) Azoospermia can be obstructive, caused by blockages, or non-obstructive, caused by testicular failure to produce sperm. Evaluation involves semen analysis, hormone testing, ultrasound, and sometimes genetic testing.
2) Management depends on the cause. For obstructive cases, surgery may correct blockages, while for non-obstructive cases, procedures like TESA may retrieve sperm for use in IVF/ICSI. Pretest
This document provides an overview of the diagnosis and management of male infertility. It discusses evaluating the patient's history including reproductive, medical, surgical, medication/toxin exposure and family histories. Physical exam and lab tests including semen analysis and hormones are also important. Common causes of male infertility discussed include varicocele, cryptorchidism, infections, cancers, medications/toxins and genetic factors. Lifestyle factors that can impact fertility are also addressed.
This document discusses the evaluation of male infertility. It outlines the various causes of male infertility including pretesticular, testicular, and post-testicular defects. The evaluation involves obtaining a history, physical exam, standard semen analysis, specialized tests such as endocrine testing and genetic tests, and specialized semen analyses to determine the underlying cause. The standard semen analysis evaluates semen volume, pH, sperm concentration, motility, morphology, round cells, and leukocytes. Abnormal findings can help localize the cause of infertility to the testes, epididymis, or other structures.
Micro-TESE as the latest option for the worst azoospermia scenariosSandro Esteves
This document summarizes information from a presentation on azoospermia and microsurgical testicular sperm extraction (Micro-TESE). It defines obstructive and non-obstructive azoospermia and compares conventional sperm retrieval techniques to Micro-TESE. Micro-TESE has higher sperm retrieval rates compared to conventional TESE, especially for men with non-obstructive azoospermia. It allows identification and preservation of the few seminiferous tubules that may contain sperm, minimizing damage to the testis.
This document summarizes male fertility and factors that impact sperm production and delivery. It discusses the roles of the hypothalamus, pituitary gland, testes and accessory sex organs in spermatogenesis and fertilization. It also outlines factors that can negatively influence sperm quality or quantity, such as varicoceles, infections, lifestyle, and occupational or environmental exposures. Evaluation of male fertility includes medical history, physical exam, semen analysis and additional tests as needed.
This document provides an overview of male infertility, including:
- Infertility is defined as the inability to conceive after 12 months of unprotected sex. Male factors contribute to infertility in about 50% of cases.
- Common causes of male infertility include abnormal semen parameters, infections, genetic factors, childhood illnesses, and exposure to toxins or radiation.
- Evaluation of male infertility involves medical history, physical exam including tests of the reproductive organs, semen analysis, and other tests like hormonal or genetic testing if indicated.
- Semen analysis evaluates semen volume, sperm concentration, motility, morphology, and other parameters to identify potential causes of infertility.
This document discusses male infertility and erectile dysfunction. It begins by defining infertility and discussing the prevalence of male factor infertility. The initial diagnostic workup is outlined, including medical history, physical exam, semen analysis, and imaging. Common causes of male infertility are then reviewed, including varicocele, testicular atrophy, orchitis, testicular microlithiasis, cryptorchidism, and various obstructive causes. Specific imaging findings of these conditions on ultrasound, MRI, and other modalities are presented.
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementAtef Darwish
This document discusses recommendations for assessing polycystic ovary syndrome (PCOS). It covers diagnostic criteria including irregular menstrual cycles, hyperandrogenism, polycystic ovarian morphology on ultrasound, and anti-Müllerian hormone levels. It also discusses assessing cardiovascular, metabolic, and reproductive health risks associated with PCOS, including insulin resistance, impaired glucose tolerance, diabetes, and obesity. Ethnic variations in PCOS presentation and long-term health risks are also addressed.
This document discusses ovarian reserve, which refers to a woman's reproductive potential and is a function of the number and quality of her remaining oocytes. It declines with age due to a reduction in both quantity and quality of oocytes. Several tests can assess ovarian reserve, including antral follicle count (AFC), anti-Müllerian hormone (AMH) levels, and follicle-stimulating hormone (FSH) levels. AFC and AMH are currently considered the best tests as they have less variability than FSH. These tests can help predict response to fertility treatments and live birth outcomes. While they provide useful information, age is still the strongest predictor of ovarian reserve and reproductive potential.
This document summarizes a presentation on the management of male infertility. It discusses diagnosis of male infertility including semen analysis and tests of sperm DNA integrity. It reviews medical treatments including antioxidants and treatments for specific conditions like varicocele and hypogonadism. Surgical treatments for varicocele are discussed. Assisted reproduction techniques are summarized including outcomes of ICSI for treated vs untreated varicocele and sperm retrieval techniques for obstructive and non-obstructive azoospermia. Key findings are that varicocele repair and antioxidant treatment can improve fertility outcomes, while sperm retrieved from the testes have lower DNA damage than ejaculated sperm.
Male Infertility Review 2011 By Paul J. Turek MD FACS, FRSM, Director of The ...The Turek Clinics
Lecture written and presented by Paul J. Turek MD FACS, FRSM. Dr. Turek is the Director of the The Turek Clinic in San Francisco and Former Professor and Endowed Chair at the University of California San Francisco (UCSF).
PROTOCOLSIntra Uterine Insemination (sharing personal experience) Lifecare Centre
This document provides information on intrauterine insemination (IUI), including prerequisites, indications, steps, and factors affecting success rates. It summarizes that IUI is a relatively simple and inexpensive fertility treatment that involves placing sperm directly into the uterus. Success rates are affected by factors like total motile sperm count, with counts over 5 million critical. Density gradient preparation is superior to swim-up for abnormal semen. DNA fragmentation levels also impact rates. Guidelines on when to consider IVF instead of further IUI cycles include age over 37, more than 4 failed cycles, severe male factors, and certain ovarian response patterns.
This document discusses male infertility, including its causes, classification, investigations, and normal semen values. It covers pre-testicular, testicular, and post-testicular causes of infertility. Key tests include semen analysis, hormonal assessment, immunological tests, and genetic testing. The document also provides details on the process and interpretation of semen analysis, including sperm motility, morphology, and vitality.
1) Evaluation of infertility is indicated after 12 months for women under 35 years old, 6 months for women over 35, and immediately for women over 40.
2) Certain conditions require immediate evaluation, including irregular cycles, bleeding issues, uterine/tubal abnormalities, male factor infertility, or genetic conditions.
3) A complete workup involves assessing the entire reproductive axis through history, examination, and targeted diagnostic testing to identify common causes like ovulatory disorders, endometriosis, tubal issues, and male factor infertility.
1) Evaluation of infertility is indicated after 12 months for women under 35 years old, 6 months for women over 35, and immediately for women over 40.
2) Testing should also be done immediately if irregular cycles, bleeding issues, uterine/tubal abnormalities, male factor infertility, or genetic conditions are present.
3) Causes of infertility include ovulatory disorders, endometriosis, pelvic adhesions, tubal blockage, tubal/uterine abnormalities, and unknown factors. A thorough evaluation of the entire reproductive system is needed.
Male infertility is caused by a variety of factors and affects around 20% of couples seeking fertility treatment. A semen analysis is used to evaluate factors like volume, pH, sperm concentration, motility, morphology, and the presence of white blood cells or agglutination. Low sperm counts or poor motility/morphology are common causes. Other causes include varicocele, infections, genetic issues, hormonal imbalances, obesity, and aging. Treatments may include lifestyle changes, medications, surgery, artificial insemination, IVF, or the use of donor sperm depending on the underlying issue. A comprehensive evaluation is needed to identify the cause and guide the most appropriate treatment plan.
Infertility is defined as the failure to conceive within one year of regular unprotected intercourse. It can be caused by issues with ovulation, the fallopian tubes, uterus, cervical factors, or the male partner's sperm production or ability to deposit sperm in the vagina. Treatment depends on the underlying cause and may include fertility drugs, surgery, artificial insemination, in vitro fertilization, or using donor gametes. The goal is to identify and address any issues reducing fertility so as to increase the chances of a successful pregnancy.
Infertility affects as many as 10% of the couples, the causes, investigations and treatment with mention of management of fibroids and endometriosis has been done in the presentation.
This document provides an overview of testicular biopsy, including:
1) The indications for testicular biopsy include evaluating infertility, distinguishing obstructive from non-obstructive causes of azoospermia, and identifying malignant germ cells.
2) The common methods are open incisional biopsy and percutaneous biopsy, with open biopsy being optimal.
3) Interpretation of biopsies in infertility involves qualitative, semi-quantitative, and quantitative analysis to assess patterns of damage and prognosis. Abnormal patterns include maturation arrest, hypospermatogenesis, and Sertoli cell-only syndrome.
Normal fertile couples of reproductive age have a conception rate of 20% to 25% per month, with more than 90% conceiving within 1 year.
Male factor infertility is involved in approximately 50% of infertile couples.
In 30% of the cases, an abnormality is discovered solely in the man.
As many as 2% of all men will exhibit suboptimal sperm parameters.
This document provides guidelines for evaluating male infertility. It discusses obtaining a history regarding infertility, sexual function, medical issues, infections, exposures to toxins, and family history. A physical exam evaluates factors like virilization, the penis, testes, and epididymis. Investigations include hormone levels, semen analysis, and tests for azoospermia like a vasogram or ultrasound. Causes of infertility are then managed medically, surgically, or with hormones depending on the specific issue found. The goal is to diagnose and address any reproductive abnormalities contributing to the couple's inability to conceive after a year of unprotected intercourse.
1. INFERTLITY and Menopouse for PG.pptxMesfinShifara
Infertility is defined as the inability to conceive after 12 months of regular unprotected intercourse. It can be caused by problems with sperm, eggs, fertilization, or implantation. Common causes include ovulatory disorders, tubal damage, male factor issues, and unexplained infertility. Diagnosis involves medical history, physical exam, semen analysis, and tests of hormone levels and fallopian tube patency. Treatment may include lifestyle changes, ovulation induction, intrauterine insemination, in vitro fertilization, or assisted reproductive technologies.
This patient presents with oligospermia and a history of gonococcal infection, suggesting possible obstructive azoospermia. Physical exam shows normal testes size and indurated epididymis. Hormonal levels are normal. Further workup would include a testicular biopsy to differentiate between obstructive versus non-obstructive causes, as reconstruction may be considered if the azoospermia is obstructive in nature. The biopsy can help determine if maturation arrest is present which could mimic an obstructive picture clinically.
This document provides information about infertility, including its definition, types, etiology, evaluation, and treatment. Some key points:
- Infertility is defined as the inability to conceive after one year of regular unprotected intercourse. Its incidence is 15-30% of couples.
- Etiology can include male factors (30%), female factors (45%), and combined or unexplained causes.
- Evaluation of male infertility involves history, physical exam, semen analysis, and potential further tests. Evaluation of female infertility involves history and physical exam and may include hormonal and imaging tests.
- Treatment depends on the underlying cause but can include lifestyle changes, medication, surgery, assisted reproductive technologies like IUI
Important causes of infertility include defective spermatogenesis, obstruction of the efferent ducts in males, and tubal issues, ovulatory disorders, and endometriosis in females. The initial investigations of an infertile couple should include a semen analysis and hormonal profiles for the female partner to check FSH, AMH, LH, prolactin, testosterone, TSH, and a midluteal progesterone test, along with an HSG or laparoscopy. A multidisciplinary approach is essential to properly evaluate and treat infertility, with counseling playing a crucial role in relieving stress and supporting decision making.
Male infertility can have many causes, both genetic and environmental. A thorough evaluation includes a history, physical exam, semen analysis, and potential hormone and imaging tests. Semen analysis evaluates parameters like volume, sperm concentration, motility, and morphology. Abnormal results on semen analysis or physical exam may indicate further tests are needed to identify potential treatable causes of infertility. The goal is to optimize the chances of natural conception or inform treatment options if needed.
Abnormal uterine bleeding (AUB) refers to any deviation from normal menstruation in terms of frequency, duration, or amount of bleeding. The document discusses various types of AUB and their potential causes, both organic and systemic. It also outlines the diagnostic approach, including medical history, physical examination, laboratory tests, ultrasound, and other imaging procedures. Treatment depends on the individual's age and may involve general measures, medical options like hormones or antifibrinolytics, or surgical interventions.
This document discusses male infertility, including definitions, prevalence, causes, evaluation, and treatment. It begins by defining infertility, subfertility, fecundability, and fecundity. It then discusses the prevalence of male infertility and various potential causes including idiopathic factors, hypothalamic/pituitary disorders, primary gonadal disorders, and sperm transport disorders. The document provides details on evaluation of male infertility through history, physical exam, semen analysis, and various specialized tests. It concludes by outlining medical and surgical treatment options.
Obstetrics and gynecology deals with women's health, including pregnancy, childbirth, and the postpartum period (obstetrics) as well as non-pregnant health issues (gynecology). Common gynecological presentations include pelvic pain, abnormal vaginal bleeding or discharge, and infertility. Infertility, defined as the inability to conceive after one year of unprotected intercourse, affects approximately 15% of reproductive couples and can be caused by issues with ovulation, sperm production or transport, or anatomical defects of the female reproductive tract. Evaluation of infertility includes medical history, physical exam, semen analysis, and tests to evaluate ovulation and the uterus and fallopian tubes.
Infertility is defined as the failure to conceive within one or more years of regular unprotected intercourse. It can be caused by male factors in around 1/3 of cases, female factors in another 1/3 of cases, and both male and female factors in the remaining cases. Common causes include problems with sperm quality, ovulation, fallopian tubes, or general health issues. Treatments depend on the underlying causes and may include ovulation induction, surgery, assisted reproductive technologies like IVF, and lifestyle changes. Proper testing and counseling of both partners is important for diagnosis and management of infertility cases.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
4. TYPES
Primary infertility:
Who never conceive
Secondary infertility:
Couples who have been fertile in the
past, but have fewer than the desired number of
children
12. Cont..
• Disorder of sperm function & motility
Immotile cilia syndrome
Infection
Immunological Infertility
• Disorder of coitus:
Impotence
Hypospadias
Chordee
Timing & frequency
13. EVALUATION/WORK UP/INDICATION
Couple should have a joint evaluation at one year, unless
the following factors are present
In male:
Bilateral cryptorchidism
Testicular torsion
Previous Unexplained infertility
Prior chemotherapy
In female:
Advanced marital age (>35 yrs)
Irregular or abnormal menstruation
Previous unexplained infertility
H/O PID
14. GOAL OF WORK UP
Identification of
▫ Reversible conditions
▫ Irreversible conditions managed by ART
▫ Irreversible conditions adversely affecting any
offspring e.g. genetic or chromosomal abnormality
▫ Medical conditions related to infertility
16. HISTORY
• Medical history
• Surgical history
• Fertility history
• Sexual history
• Family history
• Medication history
• Social history
• Occupational history
18. SURGICAL HISTORY
• Cryptorchidism, Orchidopexy
• Trauma, Torsion of testis
• Hypospadias, Varicocele
• Pelvic, bladder, retroperitoneal surgery
• Herniorrhaphy, Vasectomy
• TURP, BNI,RPLND, Lumbar sympathectomy
19. FERTILITY HISTORY
• Duration of marriage
• Previous pregnancy
• Duration of infertility
• Previous treatment for infertility
• Female evaluation
20. SEXUAL HISTORY
• Libido, Erection
• State of ejaculation
• Timing & frequency
• Lubricants, used or not
21. FAMILY HISTORY MEDICATION HISTORY
• Hypospadias
• Cryptorchidism
• Midline defects
• Exposure to diethylstilbesterol
• F/H of infertility
• Nitrofurantoin
• Alpha blocker
• Calcium channel blocker
• Cimetidine
• Sulfasalazine
• Spironolactone
• Thiazide
• Radiation
22. SOCIAL HISTORY OCCUPATIONAL HISTORY
• Smoking/tobacco
• Cocaine
• Anabolic steroids
• Exposure to ionizing radiation
• Chronic heat exposure
• Aniline dye
• Pesticides
• Heavy metals
23. PHYSICAL EXAMINATION
GENERAL EXAMINATION
To detect signs of hypogonadism (Secondary sex
characteristics)
Body hair distribution
Fat distribution
Voice
Breast
Thyroid
24. LOCAL EXAMINATION
TESTIS: Size: Length 4.6cm (3.6-5.5cm)
Breadth 2.6cm (2.1-3.2cm)
Volume 18.6cc +/- 4.0cc
Consistency : Firm (normal), Soft (abnormal)
EPIDIDYMIS: Normally placed on postero-lateral aspect
of testis
Tenderness ,Induration ,Cyst, Nodule
SPERMATIC CORD: Varicocele
Vas deferens – Present or absent (2%)
25. PENIS: Length (at least 5cm is normal),
Hypospadias , Chordee, Phimosis
DRE: Prostate - Developed or not, features of
infection (tenderness,boggyness), features of
malignancy
Seminal vesicle - Enlarged or not
26. INVESTIGATIONS
• Laboratory tests - a) Semen analysis
b) Genetic assessment
• Radiographic evaluation
• Testicular biopsy
• Vasography
27. SEMEN ANALYSIS
COLLECTION
▫ Sexual abstinence for 48-72 hours
(With each abstinence, 0.4 ml semen volume is raised up to 1
week And Sperm motility tends to fall when abstinence
period > 5 days)
▫ Collected by
• Self stimulation (masturbation)
• Intercourse with special nonspermicidal condom
• Coitus interruptus ( less ideal)
▫ Collected in a wide mouth ,clean plastic or glass bottle
▫ Specimen should be examined within 1 hour of
procurement
▫ During transit,the specimen should be kept at body
temperature
▫ 3 separate samples should be collected within period of 4-6
wks before final report
28. CONT.
Physical characteristics
• Fresh semen is a coagulum that liquefies within 15-30
minutes of ejaculation
• Normal characters :
Ejaculate volume : 1.5 – 5.5 ml
Sperm count : > 20 million /ml
Motility : >50 %
Forward progression : 2 ( scale 1-4)
Morphology : >30 % WHO normal forms
>4 % Kruger normal forms
pH : Alkaline
Increased viscosity and no clumping
29. Some Nomenclatures
• Aspermia : Absence of ejaculate or seminal fluid.
Cause - Retrograde ejaculation
Post coital urinalysis confirms the dianosis
• Normospermia : Sperm count > 20 million/ ml
• Oligospermia (Oligozoospermia) : Sperm count < 20
million / ml
Cause : Varicocele, Cryptorchidism
• Azoospermia : Absence of sperm
Cause - Ejaculatory duct obstruction
Bilateral absence of vas deference
Cyst related to epididymis
Primary testicular failure
FSH is high > 2 times than normal
30. Cont.
• Asthenospermia ( Asthenozoospermia ) : Motility < 50
% ( < 50 % motile)
• Teratozoospermia : Morphology < 30 % than normal form
• Oligoasthenoteratozoospermia : Density , Motility &
Morphology less than minimum standards of adequacy
• Pyospermia / Leucospermia :
Increase in WBC in the seminal fluid
> 1 million / ml is significant
Cause : Infection
Sensitization of immune system to sperm antigen
Low grade toxin – alcohol, cigarattes
32. Radiographic evaluation
Scrotal ultrasound
Indication :
• Patient who have hydrocele
• Abnormality of peri testicular region
• Varicocele (Color Doppler )
Findings :
• Size of testis
• Peri testicular abnormality
• Varicocele – Pampiniform venous diameter >3mm is
consider abnormal
33. Cont..
TRUS ( Transrectal ultrasound)
Indication :
• Azoospermic patient
• Semen volume < 1.5 ml
• pH – Acidic
• When semen does not coagulate
Findings :
• Anatomical evaluation of prostate, seminal vesicles,
ejaculatory duct & distal vas - tumors or congenital anomaly
Dilated seminal vesicles > 1.5 cm in width or Dilated
ejaculatory duct > 2.3 mm in association with cyst ,
calcification or stone along the duct highly suggest
obstruction
34. CT & MRI
• The advent of TRUS limits its indication
• Indications include evaluation of patient with solitary
right varicocele which may be associated with
retroperitoneal pathology and evaluation of the
nonpalpable testis
35. Testicular biopsy
• Differentiate between testicular outflow obstruction &
primary testicular failure in azoospermic patient
• Indications : In azoospermic patient, whose vas
deference is present ( detected by palpation & TRUS )
with normal hormone level ( FSH,LH,testosterone) &
normal volume of testis.
• Symmetric testis – unilateral biopsy
• Asymmetric testis – bilateral biopsy
36. Cont..
Testicular biopsy evaluates
▫ Distinction between a failure of sperm production &
obstruction within the reproductive tract
▫ The size & number of seminiferous tubules
▫ The thickness of tubular basement membrane
▫ The relative number & types of germ cell within the
seminiferous tubules
▫ The degree of fibrosis in the interstitium &
▫ The presence of condition of Leydig cells.
37. VASOGRAPHY
Indications : Azoospermic patient with -
▫ Normal testis size,
▫ Normal FSH level &
▫ Normal spermatogenesis on testis biopsy
Technique :
• Vasography involves injection of dye or contrast media
into vas deferens towards the bladder from scrotum
• If sterile saline is injected into the vas towards the
bladder & if free flow is noted , no need for injecting
contrast media into the vas.
38. Cont..
• In the film of radiograph , contrast material can
delineate the anatomy of proximal vas deferens, seminal
vesicle & ejaculatory duct and determine whether
obstruction is present.
• If an obstruction is identified on vasography , surgical
correction is recommended during the same sitting
• Sampling of vasal fluid during the same procedure can
be done & inspected under microscope to determine the
presence of sperm
If sperm present – suggests obstruction distal to that
site, i.e. no obstruction in the testis & epididymis
If sperm absent – suggests more proximal obstruction
39. Treatment
Treatment depends on the cause of infertility
Options :
a ) Surgical
b ) Medical
c ) Artificial reproductive technology (ART)
40. Azoospermia :
a ) Low volume azoospermia :
Ejaculatory duct obstruction : Transurethral resection of
ejaculatory duct ( TURED)
Congenital absence of vas deference (CAVD):
Microscopic epididymal sperm aspiration (MESA)
followed by ICSI
Midline prostatic cyst : Transurethral resection
b ) Normal volume azoospermia
Vasal or epididymal obstruction : Microsurgical
reconstruction, e.g. Vasovasostomy or
vasoepididymostomy
42. Oligoasthenoteratozoospermia
• Elimination of spermatotoxin : i.e. Cimetidine ,
Spironolactone , Nitrofurantoin
Semen analysis should be repeated 2-3 months after
elimination
• Medical therapy : ( to increase spermatogenesis )
▫ Clomiphene citrate (antiestrogen) : dose 12.5- 50 mg
/day continuously or with a 5 days rest period.
▫ Tamoxifen citrate : 10-15 mg/day for 3- 6 months
▫ Antioxidant : Glutathione 600 mg/day or, Vit E 400 –
1200 U/day
▫ Kallikrein
• Surgical therapy : For Varicocele - Ligation of the veins
43. Retrograde ejaculation :
Sympathomimetic drugs : Imipramine : 25-50 mg/bd
or, Sudafed plus : 60 mg TDS - Need to start several
days before ejaculation
If fails – Sperm harvesting technique with IUI to achieve
pregnancy
44. Anejaculation :
• Due to spinal cord injury , pelvic nerve injury
• Treatment :
Electroejaculation :
With rectal probe electroejaculation sympathetic
nerves undergo stimulation contraction of vas
deferens, seminal vesicle, prostate reflex ejaculation is
induced followed by ART
Vibratory stimulation :
High frequency penile vibration - Patient may be taught
to perform the procedure & attempt to conceive at home
with cervical insemination
46. Others :
Coital therapy :
• Coital timing, frequency (Coitus every other day around
the ovulation)
• Gonadotoxin avoidance
• Avoidance of coital lubricants